News
Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...
Levi & Korsinsky is representing the shareholder plaintiff in a suit claiming the Ozempic and Wegovy manufacturer withheld ...
Novo Nordisk is scheduled to report results for the second quarter on Wednesday. Here is what you need to know: PROFIT FORECAST: The company pre-released preliminary second-quarter numbers last week, ...
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.
Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...
New fat-busting drugs are helping public employees lose weight, but they're also busting budgets for local governments.
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...
GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite ...
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...
Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable drugs that have grown popular in recent years for their abilities to ...
Furious competition in GLP-1 drugs rebuts the anti-pharma crowd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results